+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Palatin Technologies Inc - logo

Palatin Technologies is a biopharmaceutical company that develops targeted, receptor-specific peptide therapeutics for the treatment of various diseases in the United States. The company’s leading product is Bremelanotide, which is used to treat hypoactive sexual desire disorder (HSDD). It has completed pivotal Phase 3 clinical trials. Palatin also has development programs or drug candidates for inflammatory disease indications, heart failure and fibrosis. It was founded in 1986 and is based in Cranbury, New Jersey.

Melanocortin Receptor 4 - Pipeline Review, H2 2020 - Product Thumbnail Image

Melanocortin Receptor 4 - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 83 Pages
  • Global
From
Palatin Technologies Inc (PTN:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Palatin Technologies Inc (PTN:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • December 2023
  • 89 Pages
From
Palatin Technologies Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Palatin Technologies Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • April 2024
  • 50 Pages
From
Palatin Technologies Inc (PTN) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Palatin Technologies Inc (PTN) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • October 2023
  • 60 Pages
From
Loading Indicator